North Land Pharmaceutical (300016) August 4 released 2010.5 annual report. The report showed that total operating income of the company was 109 million yuan, down 7.29% from a year earlier. The total operating profit and gross profit increased by 26.72% and 27.4% respectively in the same period, the net profit of the shareholders of the listed companies was 22.6015 million yuan, the increase was 32.94%, and the earnings per share was 0.22 yuan, down 33.33%. During the reporting period, the company's core product business and its structure have not changed significantly, pharmaceutical production business is still the core business of the company. As a result of fund-raising investment, the reporting period of drug production and investment projects in the sales volume have varying degrees of growth, revenue from a year earlier growth of 20.21%, drug production business gross profit margin than a year earlier Rose 1.32%.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
